Case File
efta-01461127DOJ Data Set 10OtherEFTA01461127
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-01461127
Pages
1
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From:
Carol Saracco
Sent:
1/21/2016 9:30:44 AM
To:
Daniel Sabba
CC:
Wayne Salit
; Todd Stevens
Subject:
RE: Jeffrey Epstein/Southern Financial LLC - Rep Risk Approval IC) Ill
Classification: For Internal use only
Wayne
Chip Packard I
I
The committee wants an updated due diligence report. Can you order a level 2 kroll report? (I think it is level 2). Thx
From: Daniel Sabba
Sent: Wednesday, January 20, 2016 2:57 PM
To: Carol Saracco
Cc: Wayne Salit; Todd Stevens; Chip Packard
Subject: FW: Jeffrey Epstein/Southern Financial LLC - Rep Risk Approval [C] [I]
Hi Carol — Wayne Salit suggested we reach out to you. Jeffrey Epstein has requested the opening of a new DBSI account
for one of his entities (Gratitude America, Ltd.). We have reached out to Wayne to clarify whether this can be done with
the approvals we have in place or whether this has to be brought to the RRC. Wayne deferred the question to you - the
email below has the specific guidance received from Jan Ford. Can you please advise if possible. Thank you, Daniel
From: Wayne Salit
Sent: Tuesday, January 19, 2016 2:10 PM
To: Daniel Sabba
Cc: Todd Stevens; Chip Packard; Jan Bornebusch
Subject: RE: Jeffrey Epstein/Southern Financial LLC - Rep Risk Approval [C] [I]
Classification: For internal use only
Dan -
As we discussed, I do not have any further guidance on whether ARRC would permit a new brokerage account for Mr.
Epstein or not. I suggest you reach to Carol Saracco from the ARRC to get more detail on the parameters of the their
guidance in the e-mail date Feb 6, 2015 below. Specifically, does the proposed new brokerage account for one of Mr.
Epstein's entities require bringing this matter back to ARRC.
Kind Regards,
Wayne Salit
Deutsche Bank Americas
=.!
From: Daniel Sabba
Sent: Tuesday, January 19, 2016 1:49 PM
To: Daniel Sabba; Wayne Salit
Cc: Todd Stevens; Chip Packard
Subject: RE: Jeffrey Epstein/Southern Financial LLC - Rep Risk Approval [C]
Hi Wayne — I tried to call and got voice mail. We wanted to follow-up on this matter — the client continues to inquire
about the opening of this account. Regards, Daniel
CONFIDENTIAL — PURSUANT TO FED. R. CRIM. P. 6(e)
DB-SDNY-0 122966
CONFIDENTIAL
SDNY_GM_00269150
EFTA01461127
Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.